Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Bladder Cancer

  Free Subscription


Articles published in BJU Int

Retrieve available abstracts of 102 articles:
HTML format
Text format



Single Articles


    October 2019
  1. TAYLOR J, Becher E, Steinberg GD
    Update on the Guideline of Guidelines: Non-Muscle Invasive Bladder Cancer.
    BJU Int. 2019 Oct 9. doi: 10.1111/bju.14915.
    PubMed     Text format     Abstract available


    September 2019
  2. JAIN RK, Grivas P, Pal SK
    Non-invasive diagnosis and monitoring of urothelial bladder cancer: are we there yet?
    BJU Int. 2019;124:361-362.
    PubMed     Text format    


    August 2019
  3. JUNG A, Nielsen ME, Crandell JL, Palmer MH, et al
    Health-Related Quality of Life among Non-Muscle-Invasive Bladder Cancer Survivors: A Population-Based Study.
    BJU Int. 2019 Aug 5. doi: 10.1111/bju.14888.
    PubMed     Text format     Abstract available


  4. FILIPPOU P, Smith AB
    A new horizon for bladder preservation in muscle-invasive bladder cancer.
    BJU Int. 2019;124:184-185.
    PubMed     Text format    


    July 2019
  5. MARTINI A, Sfakianos JP, Renstrom-Koskela L, Mortezavi A, et al
    The Natural History of Untreated Muscle Invasive Bladder Cancer.
    BJU Int. 2019 Jul 16. doi: 10.1111/bju.14872.
    PubMed     Text format     Abstract available


  6. RAI BP, Bondad J, Vasdev N, Adshead J, et al
    Robotic versus open radical cystectomy for bladder cancer in adults.
    BJU Int. 2019 Jul 15. doi: 10.1111/bju.14870.
    PubMed     Text format     Abstract available


    June 2019
  7. MCCLINTOCK TR
    Palliative care in patients with bladder cancer: an opportunity for value improvement?
    BJU Int. 2019;123:913-914.
    PubMed     Text format    


    May 2019
  8. WARD DG, Gordon NS, Boucher RH, Pirrie SJ, et al
    Targeted deep sequencing of urothelial bladder cancers and associated urinary DNA: a 23-gene panel with utility for non-invasive diagnosis and risk stratification.
    BJU Int. 2019 May 11. doi: 10.1111/bju.14808.
    PubMed     Text format     Abstract available


  9. YU EY, Nekeman D, Aaronson NK, Billingham LJ, et al
    Health-Related Quality of Life in Bladder Cancer Patients around the Time of Diagnosis.
    BJU Int. 2019 May 11. doi: 10.1111/bju.14804.
    PubMed     Text format     Abstract available


  10. SEILER R, Wyatt AW, Black PC
    Molecular landscape of muscle-invasive bladder cancer: Patient age matter?
    BJU Int. 2019 May 9. doi: 10.1111/bju.14802.
    PubMed     Text format     Abstract available


  11. MOSSANEN M, Kibel AS
    The bladder cancer conundrum: how do we treat the right tumour with the right treatment, at the right time?
    BJU Int. 2019;123:748-749.
    PubMed     Text format    


    March 2019
  12. KHETRAPAL P, Kelly JD, Catto JWF, Vasdev N, et al
    Does the robot have a role in radical cystectomy?
    BJU Int. 2019;123:380-382.
    PubMed     Text format    


    February 2019
  13. KIJIMA T, Tanaka H, Koga F, Masuda H, et al
    Selective Tetramodal Bladder Preservation Therapy Incorporating Induction Chemoradiotherapy and Consolidative Partial Cystectomy with Pelvic Lymph Node Dissection for Muscle-Invasive Bladder Cancer: Oncological and Functional Outcomes of 107 Patients.
    BJU Int. 2019 Feb 27. doi: 10.1111/bju.14736.
    PubMed     Text format     Abstract available


  14. TARIQ A, Khan SR, Vela I, Williams ED, et al
    Assessment of bladder cancer patients and carers use of internet, social media and quality of available patient centric online resources: A systematic review.
    BJU Int. 2019 Feb 24. doi: 10.1111/bju.14720.
    PubMed     Text format     Abstract available


  15. HUGAR LA, Lopa SH, Yabes JG, Yu JA, et al
    Palliative Care Use Among Patients with Bladder Cancer.
    BJU Int. 2019 Feb 13. doi: 10.1111/bju.14708.
    PubMed     Text format     Abstract available


  16. DHARIWAL R, Pindoria N, Dasgupta P, Khan MS, et al
    #Checkmate: could checkpoint inhibitors be the game changer in the fight against metastatic urothelial carcinoma?
    BJU Int. 2019;123:203-207.
    PubMed     Text format    


  17. NURMINEN P, Ettala O, Seppanen M, Taimen P, et al
    Urine cytology is a feasible tool for assessing erythematous bladder lesions after bacille Calmette-Guerin (BCG) treatment.
    BJU Int. 2019;123:246-251.
    PubMed     Text format     Abstract available


  18. KINNEAR N, O'Callaghan M, Hennessey D, Liddell H, et al
    Intra-operative cell salvage in urological surgery: a systematic review and meta-analysis of comparative studies.
    BJU Int. 2019;123:210-219.
    PubMed     Text format     Abstract available


    January 2019
  19. TAN WS, Teo CH, Chan D, Heinrich M, et al
    Mix methods approach to explore patients' perspectives on the acceptability of a urinary biomarker test in replacement of cystoscopy in bladder cancer surveillance.
    BJU Int. 2019 Jan 29. doi: 10.1111/bju.14690.
    PubMed     Text format     Abstract available


  20. BAJIC P, Wolfe AJ, Gupta GN
    Old Instillations and New Implications in Bladder Cancer: The Urinary Microbiome and Intravesical BCG.
    BJU Int. 2019 Jan 21. doi: 10.1111/bju.14683.
    PubMed     Text format     Abstract available


  21. D'ANDREA D, Soria F, Zehetmayer S, Gust KM, et al
    Diagnostic accuracy, clinical utility and influence on decision making of a methylation urine biomarker test in the surveillance of non-muscle-invasive bladder cancer.
    BJU Int. 2019 Jan 17. doi: 10.1111/bju.14673.
    PubMed     Text format     Abstract available


  22. BOERI L, Soligo M, Frank I, Boorjian SA, et al
    Cigarette smoking is associated with adverse pathological response and increased disease recurrence amongst patients with muscle-invasive bladder cancer treated with cisplatin-based neoadjuvant chemotherapy and radical cystectomy: a single-centre expe
    BJU Int. 2019 Jan 8. doi: 10.1111/bju.14612.
    PubMed     Text format     Abstract available


  23. TAN WS, Sarpong R, Khetrapal P, Rodney S, et al
    Does urinary cytology have a role in haematuria investigations?
    BJU Int. 2019;123:74-81.
    PubMed     Text format     Abstract available


    December 2018
  24. MUNARI E, Calio A, Brunelli M, Martignoni G, et al
    Predicting progression in T1 non-muscle-invasive bladder cancer: back to histology.
    BJU Int. 2018;122:914-915.
    PubMed     Text format    


    October 2018
  25. QU LG, Lawrentschuk N
    Bladder cancer surveillance in patients with spinal cord injuries.
    BJU Int. 2018 Oct 8. doi: 10.1111/bju.14582.
    PubMed     Text format     Abstract available


  26. SOLOWAY MS
    Postoperative intravesical chemotherapy has an important role in reducing subsequent bladder tumours - why is it not routine?
    BJU Int. 2018;122:525-526.
    PubMed     Text format    


    September 2018
  27. SUAREZ-IBARROLA R, Soria F, Abufaraj M, D'Andrea D, et al
    Surgical checklist impact on recurrence-free survival of non-muscle invasive bladder cancer patients undergoing transurethral resection of bladder tumor.
    BJU Int. 2018 Sep 24. doi: 10.1111/bju.14557.
    PubMed     Text format     Abstract available


    August 2018
  28. LANE G, Risk M, Fan Y, Krishna S, et al
    Persistent muscle invasive bladder cancer after neoadjuvant chemotherapy: An analysis of SEER-Medicare data.
    BJU Int. 2018 Aug 20. doi: 10.1111/bju.14529.
    PubMed     Text format     Abstract available


  29. BREYER J, Wirtz RM, Erben P, Rinaldetti S, et al
    FOXM1 overexpression is associated with adverse outcome and predicts response to intravesical instillation therapy in stage pT1 non-muscle-invasive bladder cancer (NMIBC).
    BJU Int. 2018 Aug 18. doi: 10.1111/bju.14525.
    PubMed     Text format     Abstract available


  30. HEIJNSDIJK EAM, Nieboer D, Garg T, Lansdorp-Vogelaar I, et al
    Cost-effectiveness of surveillance schedules in older adults with non-muscle-invasive bladder cancer.
    BJU Int. 2018 Aug 1. doi: 10.1111/bju.14502.
    PubMed     Text format     Abstract available


  31. GROSS T, Furrer M, Schorno P, Wuethrich PY, et al
    Reproductive organ-sparing cystectomy significantly improves continence in women after orthotopic bladder substitution without affecting oncological outcome.
    BJU Int. 2018;122:227-235.
    PubMed     Text format     Abstract available


    July 2018
  32. SMITH A, Daneshmand S, Patel S, Pohar K, et al
    Patient-reported Outcomes of Blue Light Flexible Cystoscopy with Hexaminolevulinate (HAL) in the Surveillance of Bladder Cancer: Results from a Prospective Multi-center Study.
    BJU Int. 2018 Jul 6. doi: 10.1111/bju.14481.
    PubMed     Text format     Abstract available


  33. MMEJE CO, Benson CR, Nogueras-Gonzalez GM, Jayaratna IS, et al
    Determining the optimal time for radical cystectomy after neoadjuvant chemotherapy.
    BJU Int. 2018;122:89-98.
    PubMed     Text format     Abstract available


    June 2018
  34. JEFFERIES ER, Cresswell J, McGrath JS, Miller C, et al
    Open radical cystectomy in England: the current standard of care - an analysis of the British Association of Urological Surgeons (BAUS) cystectomy audit and Hospital Episodes Statistics (HES) data.
    BJU Int. 2018;121:880-885.
    PubMed     Text format     Abstract available


    May 2018
  35. MARI A, Kimura S, Foerster B, Abufaraj M, et al
    A Systematic Review and Meta-Analysis of the impact of Lymphovascular Invasion in Bladder Cancer Transurethral Resection Specimens.
    BJU Int. 2018 May 28. doi: 10.1111/bju.14417.
    PubMed     Text format     Abstract available


  36. EREDICS K, Bretterbauer KM, Comploj E, Friedl A, et al
    Bladder cancer in nonagenarians:a multicenter study of 123 patients.
    BJU Int. 2018 May 27. doi: 10.1111/bju.14419.
    PubMed     Text format     Abstract available


  37. NA R, Wu Y, Jiang G, Yu H, et al
    Germline Mutations in DNA Repair Genes are Associated with Bladder Cancer Risk and Unfavorable Prognosis.
    BJU Int. 2018 May 4. doi: 10.1111/bju.14370.
    PubMed     Text format     Abstract available


  38. GANDHI N, Krishna S, Booth CM, Breau RH, et al
    Diagnostic accuracy of MRI for tumor staging of bladder cancer: Systematic review and Meta-Analysis.
    BJU Int. 2018 May 4. doi: 10.1111/bju.14366.
    PubMed     Text format     Abstract available


  39. MASON SJ, Catto JW, Downing A, Bottomley SE, et al
    Evaluating Patient Reported Outcome Measures (PROMs) for bladder cancer: a systematic review using the COSMIN checklist.
    BJU Int. 2018 May 3. doi: 10.1111/bju.14368.
    PubMed     Text format     Abstract available


  40. BRASSETTI A, Moller A, Laurin O, Hoijer J, et al
    Evolution of cystectomy care over an 11-year period in a high-volume tertiary referral centre.
    BJU Int. 2018;121:752-757.
    PubMed     Text format     Abstract available


    April 2018
  41. FRANSEN VAN DE PUTTE EE, Bosschieter J, van der Kwast TH, Bertz S, et al
    The WHO 1973 classification system for grade is an Important prognosticator in T1 non-muscle-invasive bladder cancer.
    BJU Int. 2018 Apr 10. doi: 10.1111/bju.14238.
    PubMed     Text format     Abstract available


  42. CHA EK, Sfakianos JP, Sukhu R, Yee AM, et al
    Poor prognosis of bladder cancer patients with occult lymph node metastases treated with neoadjuvant chemotherapy.
    BJU Int. 2018 Apr 7. doi: 10.1111/bju.14242.
    PubMed     Text format     Abstract available


  43. MOSSANEN M, Brown JC, Schrag D
    Well-being beyond the bladder. How do we improve the overall health of patients with bladder cancer?
    BJU Int. 2018;121:489-491.
    PubMed     Text format    


  44. GOFRIT ON, Pode D, Pizov G, Duvdevani M, et al
    'Very-low-risk' bladder tumours - a new entity?
    BJU Int. 2018;121:627-631.
    PubMed     Text format     Abstract available


  45. TAN WS, Tan MY, Lamb BW, Sridhar A, et al
    Intracorporeal robot-assisted radical cystectomy, together with an enhanced recovery programme, improves postoperative outcomes by aggregating marginal gains.
    BJU Int. 2018;121:632-639.
    PubMed     Text format     Abstract available


    March 2018
  46. LOTAN Y, Woldu SL, Sanli O, Black P, et al
    Modeling Cost-Effectiveness of a Biomarker-Based Approach to Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer.
    BJU Int. 2018 Mar 31. doi: 10.1111/bju.14220.
    PubMed     Text format     Abstract available


  47. MOSSANEN M, Krasnow RE, Lipsitz SR, Preston MA, et al
    Associations of specific postoperative complications with costs after radical cystectomy.
    BJU Int. 2018;121:428-436.
    PubMed     Text format     Abstract available


    February 2018
  48. SEISEN T
    Examining the role of centralisation of radical cystectomy for bladder cancer.
    BJU Int. 2018;121:165-167.
    PubMed     Text format    


  49. MINERVINI A, Vanacore D, Vittori G, Milanesi M, et al
    Florence robotic intracorporeal neobladder (FloRIN): a new reconfiguration strategy developed following the IDEAL guidelines.
    BJU Int. 2018;121:313-317.
    PubMed     Text format     Abstract available


  50. PERERA M, Papa N, Christidis D, McGrath S, et al
    The impact of the global bacille Calmette-Guerin shortage on treatment patterns: population-based data.
    BJU Int. 2018;121:169-172.
    PubMed     Text format    


  51. GUO RQ, Hong P, Xiong GY, Zhang L, et al
    Impact of ureteroscopy before radical nephroureterectomy for upper tract urothelial carcinomas on oncological outcomes: a meta-analysis.
    BJU Int. 2018;121:184-193.
    PubMed     Text format     Abstract available


    January 2018
  52. BOSSCHIETER J, van Moorselaar RJA, Vis AN, van Ginkel T, et al
    The Effect of Timing of an Immediate Instillation with Mitomycin C after Transurethral Resection in 941 Non Muscle-invasive Bladder Cancer Patients.
    BJU Int. 2018 Jan 10. doi: 10.1111/bju.14124.
    PubMed     Text format     Abstract available


  53. SU J, Zhu Q, Yuan L, Zhang Y, et al
    Transumbilical laparoendoscopic single-site radical prostatectomy and cystectomy with the aid of a transurethral port: a feasibility study.
    BJU Int. 2018;121:111-118.
    PubMed     Text format     Abstract available


    December 2017
  54. MIYAKE M, Tatsumi Y, Matsumoto H, Nagao K, et al
    Outcomes of subsequent non-muscle invasive bladder cancer treated with intravesical Bacillus Calmette-Guerin after radical nephroureterectomy for upper urinary tract urothelial carcinoma: A propensity matched analysis with primary bladder cancer.
    BJU Int. 2017 Dec 27. doi: 10.1111/bju.14111.
    PubMed     Text format     Abstract available


  55. RITCH CR, Balise R, Soodana Prakash N, Alonzo D, et al
    Propensity matched comparative analysis of survival following chemoradiation or radical cystectomy for muscle invasive bladder cancer.
    BJU Int. 2017 Dec 27. doi: 10.1111/bju.14109.
    PubMed     Text format     Abstract available



  56. Bladder cancer: diagnosis and management of bladder cancer: (c) NICE (2015) Bladder cancer: diagnosis and management of bladder cancer.
    BJU Int. 2017;120:755-765.
    PubMed     Text format    


  57. MAURICE MJ, Kaouk JH
    Robotic radical perineal cystectomy and extended pelvic lymphadenectomy: initial investigation using a purpose-built single-port robotic system.
    BJU Int. 2017;120:881-884.
    PubMed     Text format     Abstract available


  58. DASGUPTA P
    NICE guidance and the BJUI.
    BJU Int. 2017;120:743.
    PubMed     Text format    


  59. VAN HEMELRIJCK M
    Human development and its impact on genitourinary cancers.
    BJU Int. 2017;120:747-748.
    PubMed     Text format    


    November 2017
  60. AHMADI N, Clifford TG, Miranda G, Cai J, et al
    Impact of body mass index on robot-assisted radical cystectomy with intracorporeal urinary diversion.
    BJU Int. 2017;120:689-694.
    PubMed     Text format     Abstract available


  61. HUDDART RA, Birtle A, Maynard L, Beresford M, et al
    Clinical and patient-reported outcomes of SPARE - a randomised feasibility study of selective bladder preservation versus radical cystectomy.
    BJU Int. 2017;120:639-650.
    PubMed     Text format     Abstract available


  62. KINNEAR N, Smith R, Hennessey DB, Bolton D, et al
    Implementation rates of uro-oncology multidisciplinary meeting decisions.
    BJU Int. 2017;120 Suppl 3:15-20.
    PubMed     Text format     Abstract available


  63. STRATTON K
    Cystectomy for cT4 prostate cancer: the most radical treatment.
    BJU Int. 2017;120.
    PubMed     Text format    


    October 2017
  64. XIA L, Taylor BL, Newton AD, Malhotra A, et al
    Early Discharge and Post-Discharge Outcomes in Patients Undergoing Radical Cystectomy for Bladder Cancer.
    BJU Int. 2017 Oct 24. doi: 10.1111/bju.14058.
    PubMed     Text format     Abstract available


  65. SMITH AB, Jaeger B, Pinheiro LC, Edwards LJ, et al
    The impact of bladder cancer on health-related quality of life.
    BJU Int. 2017 Oct 8. doi: 10.1111/bju.14047.
    PubMed     Text format     Abstract available


  66. LIEDBERG F, Gudjonsson S, Xu A, Bendahl PO, et al
    Long-term third-party assessment of results after continent cutaneous diversion with Lundiana pouch.
    BJU Int. 2017;120:530-536.
    PubMed     Text format     Abstract available


    September 2017
  67. PICHLER R, Fritz J, Tulchiner G, Klinglmair G, et al
    Increased Accuracy of a novel mRNA-based Urine Test for Bladder Cancer Surveillance.
    BJU Int. 2017 Sep 20. doi: 10.1111/bju.14019.
    PubMed     Text format     Abstract available


  68. VETTERLEIN MW, Gild P, Kluth LA, Seisen T, et al
    Perioperative Allogeneic Blood Transfusion Does Not Adversely Impact Oncological Outcomes After Radical Cystectomy for Urinary Bladder Cancer - a Propensity Score-weighted European Multicenter Study.
    BJU Int. 2017 Sep 14. doi: 10.1111/bju.14012.
    PubMed     Text format     Abstract available


  69. LI R, Metcalfe MJ, Ferguson Rd JE, Mokkapati S, et al
    Effects of Thiazolidinedione in Patients with Active Bladder Cancer.
    BJU Int. 2017 Sep 5. doi: 10.1111/bju.14009.
    PubMed     Text format     Abstract available


  70. DUDDERIDGE T
    Positive messages for bladder cancer management in negative sentinel lymph node study.
    BJU Int. 2017;120:302-303.
    PubMed     Text format    


  71. MARCHIONI M, Primiceri G, Cindolo L, Hampton LJ, et al
    Impact of diagnostic ureteroscopy on intravesical recurrence in patients undergoing radical nephroureterectomy for upper tract urothelial cancer: a systematic review and meta-analysis.
    BJU Int. 2017;120:313-319.
    PubMed     Text format     Abstract available


  72. BLUTE ML JR, Kucherov V, Rushmer TJ, Damodaran S, et al
    Reduced estimated glomerular filtration rate (eGFR <60 mL/min/1.73 m2 ) at first transurethral resection of bladder tumour is a significant predictor of subsequent recurrence and progression.
    BJU Int. 2017;120:387-393.
    PubMed     Text format     Abstract available


  73. CHAPPIDI MR, Kates M, Tosoian JJ, Johnson MH, et al
    Evaluation of gender-based disparities in time from initial haematuria presentation to upper tract urothelial carcinoma diagnosis: analysis of a nationwide insurance claims database.
    BJU Int. 2017;120:377-386.
    PubMed     Text format     Abstract available


    August 2017
  74. WAINGANKAR N, Mallin K, Smaldone M, Egleston BL, et al
    Assessing the relative influence of hospital and surgeon volume on short-term mortality after radical cystectomy.
    BJU Int. 2017;120:239-245.
    PubMed     Text format     Abstract available


  75. MILLER C, Campain NJ, Dbeis R, Daugherty M, et al
    Introduction of robot-assisted radical cystectomy within an established enhanced recovery programme.
    BJU Int. 2017;120:265-272.
    PubMed     Text format     Abstract available


  76. CATTO JWF
    Speeding up recovery from radical cystectomy: how low can we go?
    BJU Int. 2017;120:162-163.
    PubMed     Text format    


    June 2017
  77. MCCOMBIE SP, Bangash HK, Kuan M, Thyer I, et al
    Delays in the diagnosis and initial treatment of bladder cancer in Western Australia.
    BJU Int. 2017 Jun 29. doi: 10.1111/bju.13939.
    PubMed     Text format     Abstract available


  78. AFSHAR M, Goodfellow H, Jackson-Spence F, Evison F, et al
    Centralisation of radical cystectomies for bladder cancer in England, a decade on from the 'Improving Outcomes Guidance': The case for super centralisation.
    BJU Int. 2017 Jun 8. doi: 10.1111/bju.13929.
    PubMed     Text format     Abstract available


  79. SOAVE A, Riethdorf S, Dahlem R, Minner S, et al
    Detection and oncological effect of circulating tumour cells in patients with variant urothelial carcinoma histology treated with radical cystectomy.
    BJU Int. 2017;119:854-861.
    PubMed     Text format     Abstract available


  80. KOCH MO
    Detection and oncological effect of circulating tumour cells in patients with variant urothelial carcinoma histology treated with radical cystectomy.
    BJU Int. 2017;119:816.
    PubMed     Text format    


    May 2017
  81. NGO B, Papa N, Perera M, Bolton D, et al
    Bladder cancer diagnosis during haematuria investigation - implications for practice guidelines.
    BJU Int. 2017;119 Suppl 5:53-54.
    PubMed     Text format    


  82. HAYNE D
    Bladder cancer - Old lessons yet to be learned.
    BJU Int. 2017;119 Suppl 5:7.
    PubMed     Text format    


  83. NGO B, Perera M, Papa N, Bolton D, et al
    Factors affecting the timeliness and adequacy of haematuria assessment in bladder cancer: a systematic review.
    BJU Int. 2017;119 Suppl 5:10-18.
    PubMed     Text format     Abstract available


  84. LAWRENTSCHUK N
    Bladder cancer- time for a higher profile in our region.
    BJU Int. 2017;119 Suppl 5:5.
    PubMed     Text format    


  85. NGO B, Papa N, Perera M, Bolton D, et al
    Predictors of delay to cystoscopy and adequacy of investigations in patients with haematuria.
    BJU Int. 2017;119 Suppl 5:19-25.
    PubMed     Text format     Abstract available


  86. VON LANDENBERG N, Speed JM, Trinh QD
    Do micropapillary patients benefit from chemotherapy?
    BJU Int. 2017;119:656-658.
    PubMed     Text format    


  87. DAVIS JW
    Biomarker classification, validation, and what to look for in 2017 and beyond.
    BJU Int. 2017;119:812-814.
    PubMed     Text format    


    April 2017
  88. HAYNE D, Stockler M, McCombie SP, Lawrence N, et al
    The BCG + Mitomycin trial for high risk non-muscle-invasive bladder cancer: Progress report and lessons learned.
    BJU Int. 2017 Apr 9. doi: 10.1111/bju.13873.
    PubMed     Text format     Abstract available


  89. BAILEY GC, Boorjian SA, Ziegelmann MJ, Westerman ME, et al
    Urinary collecting system invasion is associated with poor survival in patients with clear-cell renal cell carcinoma.
    BJU Int. 2017;119:585-590.
    PubMed     Text format     Abstract available


  90. HINATA N, Hussein AA, George S, Trump DL, et al
    Impact of suboptimal neoadjuvant chemotherapy on peri-operative outcomes and survival after robot-assisted radical cystectomy: a multicentre multinational study.
    BJU Int. 2017;119:605-611.
    PubMed     Text format     Abstract available


    February 2017
  91. VESKIMAE E, Neuzillet Y, Rouanne M, MacLennan S, et al
    Systematic review of the oncological and functional outcomes of pelvic organ-preserving cystectomy compared with standard radical cystectomy in women who undergo curative surgery and orthotopic neobladder substitution for bladder cancer.
    BJU Int. 2017 Feb 20. doi: 10.1111/bju.13819.
    PubMed     Text format     Abstract available


  92. SPAHN M, Morlacco A, Boxler S, Joniau S, et al
    Outcome predictors of radical cystectomy in patients with cT4 prostate cancer: A multi-institutional study of 62 patients.
    BJU Int. 2017 Feb 20. doi: 10.1111/bju.13818.
    PubMed     Text format     Abstract available


    January 2017
  93. WOLDU SL, Bagrodia A, Lotan Y
    Guideline of Guidelines - Non-Muscle Invasive Bladder Cancer.
    BJU Int. 2017 Jan 6. doi: 10.1111/bju.13760.
    PubMed     Text format     Abstract available


  94. GOLOMBOS DM, O'Malley P, Lewicki P, Stone BV, et al
    Robot-assisted partial cystectomy: perioperative outcomes and early oncological efficacy.
    BJU Int. 2017;119:128-134.
    PubMed     Text format     Abstract available


  95. THALMANN GN
    Quality improvement in cystectomy care with enhanced recovery (QUICCER) study.
    BJU Int. 2017;119:4-5.
    PubMed     Text format    


    December 2016
  96. HUSSEIN AA, Hinata N, Dibaj S, May PR, et al
    Development, Validation and Clinical Application of Pelvic Lymphadenectomy Assessment and Completion Evaluation (PLACE): Intraoperative Assessment of Lymph Node Dissection after Robot-Assisted Radical Cystectomy for Bladder Cancer.
    BJU Int. 2016 Dec 17. doi: 10.1111/bju.13748.
    PubMed     Text format     Abstract available


    October 2016
  97. ALJABERY F, Shabo I, Olson H, Gimm O, et al
    Radio-guided sentinel lymph node detection and lymph node mapping in invasive urinary bladder cancer-a prospective clinical study.
    BJU Int. 2016 Oct 31. doi: 10.1111/bju.13700.
    PubMed     Text format     Abstract available


  98. FERNANDEZ MI, Williams SB, Willis DL, Slack RS, et al
    Clinical Risk Stratification in Patients with Surgically Resectable Micropapillary Bladder Cancer.
    BJU Int. 2016 Oct 18. doi: 10.1111/bju.13689.
    PubMed     Text format     Abstract available


  99. MATARAZA JM, Gotwals P
    Recent advances in immuno-oncology and its application to urological cancers.
    BJU Int. 2016;118:506-14.
    PubMed     Text format     Abstract available


  100. LONGO N, Imbimbo C, Fusco F, Ficarra V, et al
    Complications and quality of life in elderly patients with several comorbidities undergoing cutaneous ureterostomy with single stoma or ileal conduit after radical cystectomy.
    BJU Int. 2016;118:521-6.
    PubMed     Text format     Abstract available


  101. ZHANG C, Ma X, Du J, Yao Z, et al
    MicroRNA-30a as a prognostic factor in urothelial carcinoma of bladder inhibits cellular malignancy by antagonising Notch1.
    BJU Int. 2016;118:578-89.
    PubMed     Text format     Abstract available


    June 2016
  102. MEYER CP, Rios Diaz AJ, Dalela D, Hanske J, et al
    Wound dehiscence in a sample of 1 776 cystectomies: identification of predictors and implications for outcomes.
    BJU Int. 2016;117.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Bladder Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: